O ‹³@E@ˆõ (Faculty & Staff)
 O ‘å@Šw@‰@@¶ (Graduate student)


 @‹³Žö
›Á@ —´Ÿª 
  @”ŽŽm‰Û’ö (D3_2021”N)
—›@•ô‰F


 @y‹³Žö
“nç² ^–í
  @”ŽŽm‰Û’ö (D1_2021”N) ìŒû@’qŽj

 @uŽt (—Տ°Š´õÇ•”–å Œ“) ùŒ´ “S•½    @”ŽŽm‰Û’ö (D1_2021”N) Sowmiya Sankaranarayanan

 @uŽt
Ÿ†‰í P‘¾˜N    @CŽm‰Û’ö (M2_2021”N) ’£@Œ´½

 @•‹³
‘Š‰H —RŽŒ 
  @CŽm‰Û’ö (M1_2021”N) Maniruzzaman

 @•‹³
²“¡ —S‰î 
  @CŽm‰Û’ö (M1_2021”N) 刘@œ}

 @‹ZŽti”鏑 Œ“j
¬ì ^”ü
  @CŽm‰Û’ö (M1_2021”N) Sarah Hossain

 @”ñí‹ÎuŽt ‘ê@—´—Y     O Œ¤ ‹† ¶ (Research Student)


 @
  @Œ¤‹†¶ (í‹Î) ¼ì@—T‘¾˜Y

O ”Ž Žm Œ¤ ‹† ˆõ (Post-doctoral fellowship)   @Œ¤‹†¶ (í‹Î) —›@rž^

    ‘åŠwƒ|ƒXƒhƒN Tan XinEe [Malaysia]   O Œ¤ ‹† ˆõE‹q ˆõ Œ¤ ‹† ˆõ (Guest researcher)

    JSPSƒ|ƒXƒhƒN
Aa Haeruman Azam [Indonesia]   @JSPSŒ¤‹†ˆõ  NSOFOR Chijioke Adulberth [ƒiƒCƒWƒFƒŠƒA]

    TBRFƒ|ƒXƒhƒN Kanate Thitiananpakorn [Thailand]   @‹¤“¯Œ¤‹†ˆõ ¼ì—T‘¾˜Y [‰hŒ¤‰»ŠwŠ”Ž®‰ïŽÐ‚æ‚è”hŒ­]

    ‘åŠwƒ|ƒXƒhƒN Srivani Veeranarayanan [India]   @Œ¤‹†ˆõ (“ú—§§Šw‹à) Wanchai Assavalapsakul  [ƒ^ƒC]

    ‘åŠwƒ|ƒXƒhƒN Mahadi Hassan [Bangladash]   O –¼@—_@‹³@Žö (Emeritus professors)

    ‘åŠwƒ|ƒXƒhƒN “‡Žç—SŒŽ [Japan]
  @‰‘㋳Žö ’†–ì ¹N

O u À ƒAƒ‹ƒoƒCƒg
  @‘æ“ñ‘ã–Ú‹³Žö
•½ˆä ‹`ˆê


    ŠÅŒìŠw•”Šw¶ —с@‹Õ‰¹
   


O ×‹ÛŠw•”–å•ú‰ÛŒãŒ¤‹†ƒNƒ‰ƒu‚̃ƒ“ƒo[ (Šw”N‚ð–â‚킸AŒ¤‹†‚É ‹»–¡‚ðŽ‚ÂˆãŠw•”Šw¶‚ª‹³ˆõ‚ÌŽw“±‚Ì‚à‚Æ‚ÅŽ©Žå“I‚ÈŒ¤‹†‚ðs‚¢‚Ü‚·)

  @M1 (2016”N6ŒŽŒ»Ý) ˆÉ“¡ ”ü˜a (ƒCƒgƒE ƒ~ƒ)
  @ M1 (2017”N4ŒŽŒ»Ý) ´… çq (ƒVƒ~ƒY ƒ`ƒqƒ)

  @M3 (2017”N5ŒŽŒ»Ý) Žà’J@Šw  (ƒX ƒYƒ^ƒj ƒ}ƒiƒu)
   @M3 (2017”N5ŒŽŒ»Ý) ²X–Ø O•ã (ƒTƒTƒL ƒRƒEƒXƒP)

  @M2 (2017”N8ŒŽŒ»Ý) ’@‰Ã’C  (ƒ` ƒ“ ƒˆƒVƒ^ƒc)
   @M2 (2017”N8ŒŽŒ»Ý) ’|”V“à —æò (ƒ^ƒPƒmƒEƒ` ƒŒƒ~)

  @M2 (2019”N12ŒŽŒ»Ý) ‚–ì ‘å‰Í  (ƒ^ƒJƒm ƒ^ƒCƒK)
   @M2 (2020”N1ŒŽŒ»Ý) ˆÉŠÖ Œ«ì (ƒCƒZƒL@ƒPƒ“ƒTƒN)

O •½¬28”NˆÈ~“– •”–å‚©‚ç“]o‚³‚ꂽ•û@@@@“] o æ
   Ý Ð Žž Šú

  @y‹³Žö
‰º ‘º —TŽj@®ãD‘åŠw¶Šˆ‰ÈŠw•”‰h—{Šw‰È ‹³Žö‚֏A”C
@`@•½ ¬28”N3ŒŽ

  @”Ž  Žm
Avarzed Amgalanbaartar ‹A‘, ƒ‚ƒ“ƒSƒ‹‘—§ˆã‰È‘åŠwˆãŠw•”uŽt‚֏A”C
@`@•½ ¬28”N3ŒŽ

  @ŽÀŒ±•â• ’· •l •SŒb@Šw“àˆÚ“®i•úŽËüˆãŠwuÀj @`@•½ ¬28”N4ŒŽ

  @JSPSŠO‘l“Á•ÊŒ¤‹†ˆõ Bintao Cui, Ph.D., Return to Australia (RMIT‘åŠw) @•½¬29”N‚TŒŽ`•½¬31”N4ŒŽ

  @Œ¤‹†¶i˜_•¶”ŽŽmj Î“c —Sˆê  ƒƒNƒ`ƒm[ƒoŠ”Ž®‰ïŽÐ
@`@•½ ¬31”N4ŒŽ

  @ƒ|ƒXƒhƒN ‰Í“à Œì”V@‹ž“s‘åŠw”_ŠwŒ¤‹†‰È@•‹³‚֏A”C @•½¬30”N4ŒŽ`•½¬31”N‚XŒŽ

  @”Ž  Žm
Tanit Boonsiri ‹A‘, Chulalongkorn University, ˆãŠw•”uŽt‚֏A”C
@•½¬28”N4ŒŽ`—ߘa2”N3ŒŽ

  @”Ž  Žm
‘ë@—Y‰î, Ã‰ªŒ§—§‘‡•a‰@@Á‰»ŠíŠO‰È,ˆãŽt
@•½¬29”N4ŒŽ`—ߘa3”N3ŒŽ







with president
‰iˆäŠw’·‚ƍ׋ۊw•”–å‚Ì‹³ˆõ

×‹ÛŠw•”–僁ƒ“ƒo[ 2015”N
group-photo
×‹ÛŠw•”–僁ƒ“ƒo[ 2016”N
member2015×‹ÛŠw•”–僁ƒ“ƒo[ 2017”N
with president
×‹ÛŠw•”–僁ƒ“ƒo[ 2018”N
with president
×‹ÛŠw•”–僁ƒ“ƒo[ 2019”N
with president
×‹ÛŠw•”–僁ƒ“ƒo[ 2020”N
with president
×‹ÛŠw•”–僁ƒ“ƒo[ 2021”N

 ˆÈ‰º‚͌lƒvƒƒtƒB[ƒ‹











  ›Á —´Ÿª (Longzhu Cui) ‹³Žö  (ƒƒ“ƒo[ƒy[ ƒW‚̃gƒbƒv‚Ö)
  Longzhu Cui
   Email: longzhujichi.ac.jp
Šw@—ð
º˜a60”N07ŒŽ
•½¬06”N07ŒŽ
E@—ð
º˜a60”N08ŒŽ
•½¬07”N06ŒŽ
•½¬09”N07ŒŽ
•½¬10”N07ŒŽ
•½¬14”N10ŒŽ
•½¬19”N04ŒŽ
•½¬24”N02ŒŽ
•½¬25”N12ŒŽ
•½¬27”N04ŒŽ

’†‘‘æŽlˆã‰È‘åŠwˆãŠw•” ‘²‹ÆAˆãŠwŠwŽm
’†‘‘æŽlˆã‰È‘åŠw‘åŠw‰@@Š´õÇŠw ‘²‹ÆA—Տ°ˆãŠw”ŽŽm

‘æŽlˆã‰È‘åŠw•t‘®•a‰@ (‘æˆêE‘æ“ñ•a‰@) Š´õÇ‰È@—Տ°ˆãŽtA •‹³A uŽt
WHOƒnƒ“ƒ^ƒEƒCƒ‹ƒXŒ¤‹†ƒZƒ“ƒ^[(ŠØ‘) ƒ|ƒXƒhƒN
‡“V“°‘åŠwˆãŠw•”×‹ÛŠwuÀ@‹¦—ÍŒ¤‹†ˆõ
‡“V“°‘åŠwˆãŠw•”×‹ÛŠwuÀ@•‹³
‡“V“°‘åŠwˆãŠw•”×‹ÛŠwuÀ@uŽt; @‡“V“°‘åŠw‘åŠw‰@”÷¶•¨Šw@uŽt (Œ“)
‡“V“°‘åŠwˆãŠw•”×‹ÛŠwuÀ@y‹³Žö; ‡“V“°‘åŠw‘åŠw‰@Š´õ§Œä‰ÈŠw@y‹³Žö (Œ“)
–k—¢‘åŠw  –k—¢¶–½‰ÈŠwŒ¤‹†Š@Žº’·•â²
–k—¢‘åŠw  –k—¢¶–½‰ÈŠwŒ¤‹†Š@•”’·•â²
Ž©Ž¡ˆã‰È‘åŠwˆãŠw•”Š´õE–ƉuŠwuÀ×‹ÛŠw•ª–ì@‹³Žö

  Žå—v˜_•¶iSelected Publicationsj
  [
Publications in Google Scholar including citation count]

  1. Cui L, Murakami H, Kuwahara-Arai K, Hanaki H, Hiramatsu K, Contribution of a thickened cell wall and its glutamine nonamidated component to the vancomycin resistance expressed by Staphylococcus aureus Mu50. Antimicrob Agents Chemother 2000;44: 2276-2285.@
  2. Kuroda M, Ohta T, Uchiyama I, Baba T, Yuzawa H, Kobayashi I, Cui L, Oguchi A, Aoki K, Nagai Y, Lian J, Ito T, Kanamori M, Matsumaru H, Maruyama A, Murakami H, Hosoyama A, Mizutani-Ui Y, Takahashi NK, Sawano T, Inoue R, Kaito C, Sekimizu K, Hirakawa H, Kuhara S, Goto S, Yabuzaki J, Kanehisa M, Yamashita A, Oshima K, Furuya K, Yoshino C, Shiba T, Hattori M, Ogasawara N, Hayashi H, Hiramatsu K, Whole genome sequencing of meticillin-resistant Staphylococcus aureus. Lancet 2001;357: 1225-1240.
  3. Baba T, Takeuchi F, Kuroda M, Yuzawa H, Aoki K, Oguchi A, Nagai Y, Iwama N, Asano K, Naimi T, Kuroda H, Cui L, Yamamoto K, Hiramatsu K, Genome and virulence determinants of high virulence community-acquired MRSA. Lancet 2002;359: 1819-1827.
  4. Cui L, Ma X, Sato K, Okuma K, Tenover FC, Mamizuka EM, Gemmell CG, Kim MN, Ploy MC, El-Solh N, Ferraz V, Hiramatsu K, Cell wall thickening is a common feature of vancomycin resistance in Staphylococcus aureus. J Clin Microbiol 2003;41: 5-1
  5. Hiramatsu K, Cui L, Kuwahara-Arai K, Has vancomycin-resistant Staphylococcus aureus started going it alone? Lancet 2004;364: 565-566.
  6. Cui L, Lian JQ, Neoh HM, Reyes E, Hiramatsu K, DNA microarray-based identification of genes associated with glycopeptide resistance in Staphylococcus aureus. Antimicrob Agents Chemother 2005;49: 3404-3413.
  7. Cui L, Tominaga E, Neoh HM, Hiramatsu K, Correlation between Reduced Daptomycin Susceptibility and Vancomycin Resistance in Vancomycin-Intermediate Staphylococcus aureus. Antimicrob Agents Chemother 2006;50: 1079-1082.
  8. Cui L, Iwamoto A, Lian JQ, Neoh HM, Maruyama T, Horikawa Y, Hiramatsu K, Novel mechanism of antibiotic resistance originating in vancomycin-intermediate Staphylococcus aureus. Antimicrob Agents Chemother 2006;50: 428-438.
  9. Cui L, Neoh HM, Shoji M, Hiramatsu K, Contribution of vraSR and graSR point mutations to vancomycin resistance in vancomycin-intermediate Staphylococcus aureus. Antimicrob Agents Chemother 2009;53: 1231-1234.
  10. Cui L, Isii T, Fukuda M, Ochiai T, Neoh HM, Camargo IL, Watanabe Y, Shoji M, Hishinuma T, Hiramatsu K, An RpoB mutation confers dual heteroresistance to daptomycin and vancomycin in Staphylococcus aureus. Antimicrob Agents Chemother 2010;54: 5222-5233.
  11. Cui L, Neoh HM, Iwamoto A, Hiramatsu K, Coordinated phenotype switching with large-scale chromosome flip-flop inversion observed in bacteria. Proc Natl Acad Sci U S A 2012;109: E1647-1656.
  12. Watanabe S, Cui B, Kiga K, Aiba Y, Tan X, Sato'o Y, Kawauchi M, Boonsiri T, Thitiananpakorn K, Taki Y, Li FY, Azam AH, Nakada Y, Sasahara T, Cui L.  Composition and Diversity of CRISPR-Cas13a systems in the genus Leptotrichia.@Front. Microbiol. 2019  doi:10.3389/fmicb.
  13. Kiga K, Tan X-E, Rodrigo IC, Watanabe S, Aiba Y, Satofo Y, Li F-Y, Sasahara T, Cui B, Kawauchi M, Boonsiri T, Thitiananpakorn K, Taki Y, Azam AH, Suzuki M, Penadés JR, and Cui L. Development of CRISPR-Cas13a-based antimicrobials capable of sequence-specific killing of target bacteria.@Nat Commun 11, 2934 (2020).

   Editorial Board Members of SCIENTIFIC REPORTS: https://srepeditorialsite.nature.com/users/265766-longzhu-cui





 “nç² ^–í (Shinya Watanabe) y‹³Žö@(ƒƒ“ƒo[ƒy[ƒW‚̃gƒbƒvƒw)
 
  Email: swatanabejichi.ac.jp
Šw@—ð
•½¬14”N03ŒŽ
•½¬16”N03ŒŽ
•½¬20”N03ŒŽ
E@—ð
•½¬20”N04ŒŽ
•½¬20”N05ŒŽ
•½¬23”N04ŒŽ
•½¬26”N04ŒŽ
•½¬27”N04ŒŽ
•½¬30”N11ŒŽ

“Œ‹ž—‰È‘åŠw–òŠw•”»–òŠw‰È‘²‹Æ@ŠwŽmA–òÜŽt
“Œ‹ž—‰È‘åŠw‘åŠw‰@–òŠwŒ¤‹†‰È–òŠwêUCŽm‰Û’öC—¹@CŽm
‡“V“°‘åŠw‘åŠw‰@ˆãŠwŒ¤‹†‰ÈŠ´õ§Œä‰ÈŠw”ŽŽm‰Û’öC—¹@”ŽŽm

‡“V“°‘åŠwŠ´õ§Œä‰ÈŠw@”ŽŽmŒ¤‹†ˆõ
Laboratory of Clinical InfectiousDisease, NIAID, NIH, USA@Visiting Fellow
‘—§‘Ûˆã—ÃŒ¤‹†ƒZƒ“ƒ^[Œ¤‹†Š Š´õÇ§ŒäŒ¤‹†•” Š´õÇ–Ɖuˆâ“`Œ¤‹†Žº ã‹‰Œ¤‹†ˆõ
‘—§‘Ûˆã—ÃŒ¤‹†ƒZƒ“ƒ^[Œ¤‹†Š •aŒ´”÷¶•¨ŠwŒ¤‹†Žº@ã‹‰Œ¤‹†ˆõ
Ž©Ž¡ˆã‰È‘åŠwˆãŠw•”Š´õE–ƉuŠwuÀ×‹ÛŠw•ª–ì@uŽt
Ž©Ž¡ˆã‰È‘åŠwˆãŠw•”Š´õE–ƉuŠwuÀ×‹ÛŠw•ª–ì@y‹³Žö

  Žå—v˜_•¶iSelected Publications)

  1. Watanabe S, Ito T, Takeuchi F, Endo M, Okuno E, Hiramatsu K. Structural comparison of ten serotypes of staphylocoagulases in Staphylococcus aureus. J Bacteriol. 2005 Jun;187(11):3698-707.
  2. Watanabe S, Ito T, Morimoto Y, Takeuchi F, Hiramatsu K. Precise excision and self-integration of a composite transposon as a model for spontaneous large-scale chromosome inversion/deletion of the Staphylococcus haemolyticus clinical strain JCSC1435. J Bacteriol 2007; 189(7):2921-5.
  3. Watanabe S, Ito T, Hiramatsu K. Susceptibilities of healthcare- and community-associated methicillin-resistant staphylococci to the novel des-F(6)-quinolone DX-619. J Antimicrob Chemother 2007; 60(6):1384-7.
  4. Watanabe S, Ito T, Sasaki T, Li S, Uchiyama I, Kishii K, Kikuchi K, Skov RL, Hiramatsu K. Genetic diversity of staphylocoagulase genes (coa): insight into the evolution of variable chromosomal virulence factors in Staphylococcus aureus. PLoS One 2009; 4(5):e5714.
  5. Watanabe S, Goodwin M, Barry CE 3rd, Boshoff HI. Fumarate Reductase Activity Maintains an Energized Membrane in Anaerobic Mycobacterium tuberculosis. PLoS Pathog 2011; 7(10):e1002287.
  6. Watanabe S, Shimomura Y, Ubukata K, Kirikae T, Miyoshi-Akiyama T. Concomitant regulation of host tissue-destroying virulence factors and carbohydrate metabolism during invasive diseases induced by group G streptococci. J Infect Dis 2013; 208(9):1482-93.
  7. Watanabe S, Kirikae T, Miyoshi-Akiyama T. Complete genome sequence of Streptococcus dysgalactiae subsp. equisimilis 167 carrying Lancefield group C antigen and comparative genomics of S. dysgalactiae subsp. equisimilis strains. Genome Biol Evol 2013; 5(9):1644-51.
  8. Watanabe S, Takemoto N, Ogura K, Miyoshi-Akiyama T. Severe invasive streptococcal infection by Streptococcus pyogenes and Streptococcus dysgalactiae subsp. equisimilis. Microbiol Immunol. 2016 60(1):1-9.
  9. Watanabe S, Matsumura K, Iwai H, Funatogawa K, Haishima Y, Fukui C, Okumura K, Kato-Miyazawa M, Hashimoto M, Teramoto K, Kirikae F, Miyoshi-Akiyama T, Kirikae T. A Mutation in the 16S rRNA Decoding Region Attenuates the Virulence of Mycobacterium tuberculosis. Infect Immun. 2016. 84(8):2264-73.
  10. Watanabe S, Sasahara T, Arai N, Sasaki K, Aiba Y, Sato'o Y, Cui L. Complete Genome Sequence of Streptococcus pyogenes Strain JMUB1235 Isolated from an Acute Phlegmonous Gastritis Patient. Genome Announc. 2016. 4(5).
  11. Watanabe S, Cui B, Kiga K, Aiba Y, Tan X, Sato'o Y, Kawauchi M, Boonsiri T, Thitiananpakorn K, Taki Y, Li FY, Azam AH, Nakada Y, Sasahara T, Cui L.  Composition and Diversity of CRISPR-Cas13a systems in the genus Leptotrichia.@Front. Microbiol. 2019  doi:10.3389/fmicb.



Ÿ†‰í P‘¾˜N (Kotaro Kiga)  uŽt@(ƒƒ“ƒo[ƒy[ƒW‚̃gƒbƒvƒw)
 
  Email: k-kigajichi.ac.jp
Šw@—ð
•½¬17”N03ŒŽ
•½¬19”N03ŒŽ
•½¬23”N03ŒŽ
E@—ð
•½¬20”N04ŒŽ
•½¬23”N04ŒŽ
•½¬26”N03ŒŽ
•½¬26”N11ŒŽ
•½¬28”N09ŒŽ

“Œ‹ž‘åŠw HŠw•” ‰»Šw¶–½HŠw‰È‘²‹Æ ŠwŽm
“Œ‹ž‘åŠw HŠwŒnŒ¤‹†‰È ‰»Šw¶–½HŠwêU CŽm‰Û’öC—¹ CŽm
“Œ‹ž‘åŠw ˆãŠwŒnŒ¤‹†‰È •aˆöE•a—ŠwêU ”ŽŽm‰Û’öC—¹ ”ŽŽm

“ú–{ŠwpU‹»‰ï“Á•ÊŒ¤‹†ˆõiDC1j
Max-Planck-Institute of Immunobiology and Epigenetics ƒhƒCƒc ”ŽŽmŒ¤‹†ˆõ
“Œ‹ž‘åŠw ˆã‰ÈŠwŒ¤‹†Š Š´õÇ‘ÛŒ¤‹†ƒZƒ“ƒ^[ Š´õ§ŒäŒn ×‹ÛŠw•ª–ì “Á”CŒ¤‹†ˆõ
“Œ‹ž‘åŠw ˆã‰ÈŠwŒ¤‹†Š Š´õÇ‘ÛŒ¤‹†ƒZƒ“ƒ^[ Š´õ§ŒäŒn ×‹ÛŠw•ª–ì “Á”C•‹³

Ž©Ž¡ˆã‰È‘åŠw ˆãŠw•” Š´õE–ƉuŠwuÀ ×‹ÛŠw•ª–ì uŽt

  Žå—v˜_•¶iSelected Publicationsj

  1. Fukao T, Fukuda Y, Kiga K, Sharif J, Hino K, Enomoto Y, Kawamura A, Nakamura K, Takeuchi T, Tanabe M. An evolutionarily conserved mechanism for microRNA-223 expression revealed by microRNA gene profiling. Cell 2007;129(3): p617-631.
  2. Suzuki M, Mimuro H, Kiga K, Fukumatsu M, Ishijima N, Morikawa H, Nagai S, Koyasu S, Gilman R, Kersulyte D, Berg D, Sasakawa C. Helicobacter pylori CagA Phosphorylation-Independent Function in Epithelial Proliferation and Inflammation. Cell Host Microbe 2009;5(1): p23-34.
  3. Suzuki M, Kiga K, Kersulyte D, Cok J, Hooper C, Mimuro H, Sanada T, Suzuki S, Oyama M, Kozuka-Hata H, Kamiyae S, Zou Q, Gilman R, Berg D, Sasakawa C. Attenuated CagA Oncoprotein in Helicobacter pylori from Amerindians in Peruvian Amazon. J Biol Chem 2011;286(34): p29964-29972.
  4. Iwasaki Y*, Kiga K*, Kayo H, Fukuda-Yuzawa Y, Weise J, Inada T, Tomita M, Ishihama Y, Fukao T. Global microRNA elevation by inducible Exportin 5 regulates cell cycle entry. RNA 2013;19(4): p490-497.
  5. Kayo H*, Kiga K*, Fukuda-Yuzawa Y*, Hedlund S, Murakami K, Rosa-Velazquez I, Kimura T, Shimoda K, Tanabe M, Fukao T. miR-212 and miR-132 are dispensable for mouse mammary gland development. Nature Genet 2014;46(8): p802-804.
  6. Kiga K*, Mimuro H*, Suzuki M, Shinozaki-Ushiku A, Kobayashi T, Sanada T, Kim M, Ogawa M, Iwasaki Y, Kayo H, Fukuda-Yuzawa Y, Yashiro M, Fukayama M, Fukao T, Sasakawa C. Epigenetic silencing of miR-210 increases the proliferation of gastric epithelium during chronic Helicobacter pylori infection. Nat Commun 2014; 5:4497.
  7. Kiga K#, Fukuda-Yuzawa Y, Tanabe M, Tsuji S, Sasakawa C, Fukao T#. Comprehensive silencing of target-sharing microRNAs is a mechanism for SIRT1 overexpression in cancer. RNA Biol 2014;11(11): p1347-1354.
  8. Kiga K, Tan X-E, Rodrigo IC, Watanabe S, Aiba Y, Satofo Y, Li F-Y, Sasahara T, Cui B, Kawauchi M, Boonsiri T, Thitiananpakorn K, Taki Y, Azam AH, Suzuki M, Penadés JR, and Cui L. Development of CRISPR-Cas13a-based antimicrobials capable of sequence-specific killing of target bacteria.@Nat Commun 11, 2934 (2020) .

    (*: Co-first authors; #: Corresponding author)





 ²“¡—S‰î (Yusuke Sato'o) •‹³@(ƒƒ“ƒo[ƒy[ƒW‚̃gƒbƒvƒw)
 
  Email: syusukejichi.ac.jp
Šw@—ð
•½¬23”N03ŒŽ
•½¬26”N09ŒŽ
(•½¬24”N10ŒŽ-
•½¬26”N09ŒŽ)

E@—ð
•½¬26”N10ŒŽ
•½¬27”N04ŒŽ

ŠâŽè‘åŠw”_Šw•”bˆãŠw‰È‘²‹Æ@ŠwŽmAbˆãŽt
Šò•Œ‘åŠw‘åŠw‰@˜A‡bˆãŠwŒ¤‹†‰È‘²‹Æ@”ŽŽm 

(L“‡‘åŠw‘åŠw‰@ˆãŽ•–ò•ÛŒ’ŠwŒ¤‹†‰È “Á•ÊŒ¤‹†Šw¶ )


L“‡‘åŠw‘åŠw‰@ˆãŽ•–ò•ÛŒ’ŠwŒ¤‹†‰È@Œ¤‹†ˆõ
Ž©Ž¡ˆã‰È‘åŠwˆãŠw•”Š´õE–ƉuŠwuÀ×‹ÛŠw•ª–ì@•‹³

  Žå—v˜_•¶iSelected Publicationsj

  1. Sato'o Y, Omoe K, Ono HK, Nakane A, Hu DL.  A novel comprehensive analysis method for Staphylococcus aureus pathogenicity islands. Microbiology and Immunology. 2013; 57:91-99.
  2. Sato'o Y, Omoe K, Naito I, Ono HK, Nakane A, Sugai M, Yamagishi N, Hu DL. Molecular Epidemiology and Identification of a Staphylococcus aureus Clone Causing Food Poisoning Outbreaks in Japan. Journal of Clinical Microbiology. 2014; 52:2637-2640.
  3. Satofo Y, Hisatsune J, Nagasako Y, Ono HK, Omoe K, Sugai M. Positive regulation of staphylococcal enterotoxin H by repressor of toxin and its importance in food poisoning in CC81 subtype-1 lineage. Appl Environ Microbiol 2015; 81: 7782-7790.
  4. Ono HK, Sato'o Y, Narita K, Naito I, Hirose S, Hisatsune J, Asano K, Hu DL, Omoe K, Sugai M, Nakane A. 2015. Identification and Characterization of a Novel Staphylococcal Emetic Toxin. Appl Environ Microbiol 2015; 81: 7034-7040.
  5. Hisatsune J, Sato'o Y, Yu L, Kutsuno S, Hayakawa Y, Sugai M. Efficient transformation of Staphylococcus aureus using multi-pulse electroporation. J Microbiol Methods 2016; 130:69-72.
  6. Sato'o Y, Hisatsune J, Hirakawa H, Ono HK, Omoe K, Sugai M. 2017. Complete Sequence of a Staphylococcus aureus Clonal Complex 81 Strain, the Dominant Lineage in Food Poisoning Outbreaks in Japan. Genome Announc. 5: e00853-17.
  7. Sato'o Y, Hisatsune J, Yu L, Sakuma T, Yamamoto T, Sugai M. 2018. Tailor-made gene silencing of Staphylococcus aureus clinical isolates by CRISPR interference. PLoS One. 13:e0185987.
  8. Sato'o Y, Aiba Y, Kiga K, Watanabe S, Sasahara T, Hayakawa Y, Cui L. 2018. Optimized universal protocol for electroporation of both coagulase-positive and -negative Staphylococci. J Microbiol Methods. 146:25-32.





 ‘Š‰H —RŽŒ (Yoshifumi Aiba) •‹³@(ƒƒ“ƒo[ƒy[ƒW‚̃gƒbƒvƒw)
 
   Email: y-aibajichi.ac.jp
Šw@—ð
•½¬15”N03ŒŽ
•½¬17”N03ŒŽ
•½¬23”N03ŒŽ
•½¬26”N03ŒŽ

E@—ð
•½¬17”N04ŒŽ
•½¬17”N12ŒŽ
•½¬19”N04ŒŽ
•½¬21”N04ŒŽ
•½¬26”N04ŒŽ
•½¬27”N12ŒŽ

“Œ‹ž”_‹Æ‘åŠw ‰ž—p¶•¨‰ÈŠw•” ø‘¢‰ÈŠw‰È@ŠwŽm@‘²‹Æ
“Œ‹ž”_‹Æ‘åŠw‘åŠw‰@ ”_ŠwŒ¤‹†‰È ø‘¢ŠwêU@”ŽŽm‘OŠú‰Û’ö@CŽm@C—¹
“Œ‹ž‘åŠw‘åŠw‰@ •ªŽq×–E¶•¨ŠwŒ¤‹†Š@ƒoƒCƒIƒŠƒ\[ƒVƒXŒ¤‹†•ª–ì@Œ¤‹†¶
‡“V“°‘åŠw‘åŠw‰@ ˆãŠwŒ¤‹†‰È Š´õ§Œä‰ÈŠw ”ŽŽm‰Û’ö@”ŽŽmiˆãŠwjC—¹@


‚±‚¢‚µ‚âH•iŠ”Ž®‰ïŽÐ
‚ ‚݈óH•iH‹ÆŠ”Ž®‰ïŽÐ@“Œ‹ž”_‹Æ‘åŠw@Žó‘õŒ¤‹†ˆõ
—LŒÀ‰ïŽÐFETEƒCƒmƒx[ƒVƒ‡ƒ“@“Œ‹ž‘åŠw@Žó‘õŒ¤‹†ˆõ
“Œ‹ž‘åŠw‘åŠw‰@ •ªŽq×–E¶•¨ŠwŒ¤‹†ŠƒoƒCƒIƒŠƒ\[ƒVƒXŒ¤‹†•ª–ì “Á•ÊŒ¤‹†ˆõ
‡“V“°‘åŠw‘åŠw‰@ˆãŠwŒ¤‹†‰È@Š´õ§Œä‰ÈŠwŒ¤‹†ƒZƒ“ƒ^[ @”ŽŽmŒ¤‹†ˆõ
Ž©Ž¡ˆã‰È‘åŠwˆãŠw•”Š´õE–ƉuŠwuÀ×‹ÛŠw•ª–ì@•‹³
  Žå—v˜_•¶iSelected Publicationsj
  1. Thitiananpakorn K, Aiba Y, Tan XE, Watanabe S, Kiga K, Satofo Y, Boonsiri T, Li FY, Sasahara T, Taki Y, Azam AH, Zhang YC, Cui L. Association of mprF mutations with cross-resistance to daptomycin and vancomycin in methicillin-resistant Staphylococcus aureus (MRSA). Scientific Reports, 2020, 10(1): 16107.
  2. Kiga K, Tan X-E, Rodrigo IC, Watanabe S, Aiba Y, Satofo Y, Li F-Y, Sasahara T, Cui B, Kawauchi M, Boonsiri T, Thitiananpakorn K, Taki Y, Azam AH, Suzuki M, Penadés JR, and Cui L. Development of CRISPR-Cas13a-based antimicrobials capable of sequence-specific killing of target bacteria. Nature Communications, 2020, 11, 2934.
  3. Aiba Y, Watanabe S, Tsukahara R, Umemoto N, Thitiananpakorn K, Boonsiri T, Li F-Y, Kiga K, Satofo Y, Tan X-E, Taki Y, Azam AH, Zhang Y, Sasahara T, Demitsu T, Cui L. Complete Genome Sequence of a Panton-Valentine Leukocidin-Negative Staphylococcus aureus Strain Isolated from a Patient with Pervasive Necrotizing Soft Tissue Infection. Microbiology Resource Announcements Jun 2020, 9 (23) e00295-20.
  4. Kanesaka I, Fujisaki S, Aiba Y, Watanabe S; Mikawa T, Katsuse A K, Takahashi H, Cui L, Kobayashi I. Characterization of compensatory mutations associated with restoration of daptomycin-susceptibility in daptomycin non-susceptible methicillin-resistant Staphylococcus aureus and the role mprF mutations. Journal of Infection and Chemotherapy. Volume 25, Issue 1, January 2019, Pages 1-5.
  5. Aiba Y, Katayama Y, Hishinuma T, Murakami-Kuroda H, Cui L, Hiramatsu K. Mutation of RNA polymerase ƒÀ-subunit gene promotes heterogeneous-to-homogeneous conversion of ƒÀ-lactam resistance in methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother. 2013 Oct;57(10):4861-71.
  6. Yabe S, Aiba Y, Sakai Y, Hazaka M, Yokota A. Thermosporothrix hazakensis gen. nov., sp. nov., isolated from compost, description of Thermosporotrichaceae fam. nov. within the class Ktedonobacteria Cavaletti et al. 2007 and emended description of the class Ktedonobacteria. Int J Syst Evol Microbiol. 2010 Aug;60(Pt 8):1794-801.






 ùŒ´“S•½ (Teppei Sasahara) uŽtiŠw“àEŒ“j(ƒƒ“ƒo[ƒy[ƒW‚̃gƒbƒvƒw)
  sasahara
   Email: protozoajichi.ac.jp
Šw@—ð
•½¬15”N03ŒŽ
•½¬22”N03ŒŽ

E@—ð
•½¬15”N05ŒŽ
•½¬17”N05ŒŽ
•½¬18”N04ŒŽ
•½¬22”N04ŒŽ
•½¬27”N01ŒŽ

ŽD–yˆã‰È‘åŠwˆãŠw•”‘²‹Æ@ˆãŠwŠwŽm
Ž©Ž¡ˆã‰È‘åŠwˆãŠw•”ˆãŠwŒ¤‹†‰È”ŽŽm‰Û’ö@‘²‹ÆAˆãŠw”ŽŽm


‘—§‘Ûˆã—ÃZƒ“ƒ^[@—Տ°Œ¤Cˆã
‘—§‘Ûˆã—ÃZƒ“ƒ^[@‘‡f—ÉȃVƒjƒAƒŒƒWƒfƒ“ƒg
Ž©Ž¡ˆã‰È‘åŠw•‘®•a‰@@—Տ°Š´õÇƒZƒ“ƒ^[Š´õ§Œä•”EŠ´õÇ‰ÈƒtƒFƒ[
Ž©Ž¡ˆã‰È‘åŠwˆãŠw•”@Š´õE–ƉuŠwuÀ×‹ÛŠw•”–å@•‹³
Ž©Ž¡ˆã‰È‘åŠwˆãŠw•”@Š´õE–ƉuŠwuÀ—Տ°Š´õÇŠw•”–å@Šw“àuŽt
@ê–åˆã“™
@“ú–{Š´õÇŠw‰ï@Š´õÇŽw“±ˆãEê–åˆã
@“ú–{‰»Šw—Ö@Šw‰ï@R‹Û‰»Šw—Ö@Žw“±ˆãE”F’èˆã
@“ú–{“à‰ÈŠw‰ï@‘‡“à‰Èê–åˆã
@“ú–{«Š´õÇŠw‰ï@«Š´õÇ”F’èˆã
@“ú–{ˆãŽt‰ï@”F’èŽY‹Æˆã
@ICD§“x‹¦‹c‰ï@ƒCƒ“ƒtƒFƒNƒVƒ‡ƒ“EƒRƒ“ƒgƒ[ƒ‹EƒhƒNƒ^[
 
  Žå—v˜_•¶iSelected Publicationsj

  1. Sasahara T, Hayashi S, Hosoda K, Morisawa Y, and Hirai Y. Comparison of Hand Hygiene Procedures for Removing Bacillus cereus Spores. Biocontrol Sci 2014;19:129-134.
  2. Sasahara T, Hayashi S, Morisawa Y, Sakihama T, Yoshimura A, Hirai Y. Bacillus cereus bacteremia outbreak due to contaminated hospital linens. Eur J Clin Microbiol Infect Dis 2011;30:219-26.
  3. Oda M, Hashimoto M, Takahashi M, Ohmae Y, Seike S, Kato R, Fujita A, Tsuge H, Nagahama M, Ochi S, Sasahara T, Hayashi S, Hirai Y, Sakurai J. Role of sphingomyelinase in infectious diseases caused by Bacillus cereus. PLoS One 2012;7:e38054.
  4. Ogawa M and Sasahara T. A pilot study on the stability of toluene in blood from workers. J Occup Med Toxicol 2012;7:24.





 ¬ì ^”ü (Mami Ogawa) ‹ZŽti”鏑Œ“j(ƒƒ“ƒo[ƒy[ƒW‚̃gƒbƒvƒw)
 
   Email: mogawajichi.ac.jp


 






 [ŽÀ‚µ‚½–ˆ“ú‚ª‰ß‚²‚¹‚é—lAŠF‚³‚ñ‚Æ‹¦—Í‚µ‡‚¢AŠy‚µ‚¢Eê‚ð“úX–ÚŽw‚µ‚½‚¢‚ÆŽv ‚¢‚Ü‚·B




  ’†–ì ¹N (Masayasu Nakano) –¼—_‹³Žö@(ƒƒ“ƒo[ƒy[ƒW‚̃gƒbƒvƒw)
Hirai
E@—ð
1973”N-1996”N


@Ž©Ž¡ˆã‰È‘åŠw ×‹ÛŠw•ª–ì@‹³Žö (‰‘㋳Žö)





  •½ˆä ‹`ˆê (Yoshikazu Hirai) –¼—_‹³ŽöA”ñí‹ÎuŽt@(ƒƒ“ƒo[ƒy[ƒW‚̃gƒbƒvƒw)
Hirai
E@—ð
1997”N-2014”N
2015”N4ŒŽ `


@Ž©Ž¡ˆã‰È‘åŠw ×‹ÛŠw•ª–ì@‹³Žö (‘æ‚Q‘ã–Ú‹³Žö)
@‹Ê–쑍‡ˆã—Ðê–åŠwZ@Z’·





  ‘ê@—´—Y (Tatsuo Taki) ”ñí‹ÎuŽt@(ƒƒ“ƒo[ƒy[ƒW‚̃gƒbƒvƒw)
 

Šw@—ð
1971”N3ŒŽ1973”N3ŒŽ
1982”N10ŒŽ

E@—ð
1973”N4ŒŽ1979”N(‚P”N)
1984”N4ŒŽ
1990”N10ŒŽ1994”N4ŒŽ
2014”N3ŒŽ2016”N4ŒŽ


–k—¢‘åŠw‰q¶Šw•”‰q¶ŒŸ¸Šw‰È‘²‹Æ •ÛŒ’‰q¶ŠwŽm

–k—¢‘åŠw‘åŠw‰@‰q¶ŠwŒ¤‹†‰ÈCŽm‰Û’öC—¹@•ÛŒ’ŠwCŽm
–k—¢‘åŠw‘åŠw‰@‰q¶ŠwŒ¤‹†‰È@ŠwˆÊŽæ“¾@ŠwpŠw”ŽŽmi–k—¢‘åŠwj


Ž©Ž¡ˆã‰È‘åŠwˆãŠw•””÷¶•¨Šw‹³Žº@•Žè
USAƒJƒ“ƒUƒXBƒJƒ“ƒUƒXB—§‘åŠwˆãŠw•” ƒŠƒT[ƒ`EƒAƒVƒXƒ^ƒ“ƒg
Ž©Ž¡ˆã‰È‘åŠwˆãŠw•””÷¶•¨Šw‹³Žº@uŽt
–k—¢‘åŠw‰q¶Šw•””÷¶•¨Šw‹³Žº@•‹³Žö
–k—¢‘åŠwˆã—Éq¶Šw•””÷¶•¨Šw‹³Žº@y‹³Žö
–k—¢‘åŠwˆã—Éq¶Šw•”@’è”N‘ސE
Ž©Ž¡ˆã‰È‘åŠwˆãŠw•”Š´õE–ƉuŠwuÀ×‹ÛŠw•ª–ì@”ñí‹ÎuŽt

  Žå—v˜_•¶iSelected Publicationsj

  1. Saito T, Nakano M. Effect of bacterial lipopolysaccharides on anti-trinitrophenyl antibody producing cells: Non-specific modulation of the affinity at cellular level. Jpn J Microbiol 1975;19:419-425.
  2. Saito-Taki T, Toyoda H, Nakano M. Immunological properties of heat-killed thermophilic bacteria. Microbiol Immunol 1979;23:1141-1145.
  3. Suzuki T, Saito-Taki T, Sadasivan R, Nitta T. Biochemical signal transmitted by Fc? receptors: Phospholipase A2 activity of Fc?2b receptor of murine macrophage cell line P388D1. Proc Natl Acad Sci USA 1982;79(1):591-595.
  4. Saito-Taki T, Nakano M. Suppression of lipopolysaccharide-induced polyclonal B cell activation of murine spleen with heat-aggregated murine immunoglobulin G. J
    Immunol 1983;130(5):2022-2026.
  5. Saito-Taki T, Suzuki T, Nakano M. IgG2b-dependent down regulation of the LPS-induced PFC-response and its blockade by Fc?2bR protein. Int J Immunopharm 1990;12(3):278-287.
  6. Han HJ1, Taki T, Kondo H, Hirono I,Aoki T Pathogenic potential of a collagenase gene from Aeromonas veronii. Can J Microbiol 2008;54(1):1-10.
  7. Onogawa T, Saito-Taki T, Yamamoto H, Wada T. IL6 trans-signaling promotes
    functional recovery of hypofunctional phagocytes through STAT3 activation during peritonitis.@Inflamm Res@2013;62(8):797-810.



   XinEe Tani ƒ^ƒ“ ƒVƒ“ƒC[ j, Ph.D.  ƒ|ƒXƒhƒN@(ƒƒ“ƒo[ƒy[ƒW‚̃gƒbƒvƒw)

   Email: xineejichi.ac.jp 

Šw@—ð
`2017”N9ŒŽ

E@—ð
2017”N10ŒŽ`


@ƒ}ƒŒ[ƒVƒA‘–¯‘åŠw


@Ž©Ž¡ˆã‰È‘åŠw ˆãŠw•” Š´õE–ƉuŠwuÀ ×‹ÛŠw•”–å@


  Žå—v˜_•¶iSelected Publicationsj
  1. Noordin A., Sapri H.F., Mohamad Sani N.A., Leong S.K., Tan X.E., Tan T.L., Mohamad Zin N., Neoh H. and Hussin S. Antimicrobial resistance profiling and molecular typing of methicillin-resistant Staphylococcus aureus (MRSA) isolated from a Malaysian Teaching Hospital. Journal of Medical Microbiology. Accepted for publication, November 5th 2016.
  2. Tan X.E., Neoh H., Looi M., Tan T.L., Hussin S., Cui L., Hiramatsu K. and Jamal R. Comparative proteomics profiling reveals down-regulation of Staphylococcus aureus virulence in achieving intermediate vancomycin resistance. Accepted for publication in Malaysian Journal of Microbiology Special Issue on October 20th 2016.
  3. Tan X.E., Neoh H., Looi M., Chin S.F., Cui L., Hiramatsu K., Hussin S. and Jamal R. Activated ADI pathway: the initiator of intermediate vancomycin resistance in Staphylococcus aureus. DOI: 10.1139/cjm-2016-0439. Accepted for publication in Canadian Journal of Microbiology on October 19th 2016.
  4. Neoh, H., Mohamed-Hussein, Z.A., Tan, X.E., Raja Abd Rahman, R.M.F., Hussin, S., Mohamad Zin, N. dan Jamal, R. 2013. Draft genome sequences of four nosocomial methicillin-resistant Staphylococcus aureus (MRSA) strains (PPUKM-261-2009, PPUKM-332-2009, PPUKM-377-2009, and PPUKM-775-2009) representative of dominant MRSA pulsotypes circulating in a Malaysian University Teaching Hospital. Genome Announcements (1). doi:pii: e00103-12.10.1128/genomeA.00103-12.
  5. Xin Ee Tan, Hui-min Neoh, Salasawati Hussin, Noraziah Mohamad Zin. 2013. Clonal distribution and possible microevolution of methicillin-resistant Staphylococcus aureus strains in a teaching hospital in Malaysia. Asian Pacific Journal of Tropical Biomedicine 3(3). 






Aa Haeruman Azam, Ph.D. ƒ|ƒXƒhƒN (ƒƒ“ƒo[ƒy[ƒW‚̃gƒbƒvƒw)

Šw@—ð
•½¬22”N06ŒŽ
•½¬27”N03ŒŽ
•½¬31”N03ŒŽ


E@—ð
•½¬25”N04ŒŽ

•½¬31”N04ŒŽ
—ߘa2”N04ŒŽ

Bachelor of Science, Bandung Institute of Technology, Indonesia
Master of Engineering, “Œ‹žH‹Æ‘åŠw
Doctor of Engineering, “Œ‹žH‹Æ‘åŠw



Assistant researcher, PT Astra Agro Lestari, Indonesia
Ž©Ž¡ˆã‰È‘åŠw ˆãŠw•” Š´õE–ƉuŠwuÀ ×‹ÛŠw•”–å

Ž©Ž¡ˆã‰È‘åŠw ˆãŠw•” Š´õE–ƉuŠwuÀ ×‹ÛŠw•”–åiJSPSŠO‘l“Á•ÊŒ¤‹†ˆõ(ˆê”Ê))

@Žå—v˜_•¶iSelected Publicationsj

  1. Azam AH., Kadoi K, Miyanaga K, Tamura M, Cui L, Tanji Y, Analysis host-recognition mechanism of staphylococcal kayvirus ƒ³SA039 reveals a novel strategy that protects S. aureus against infection by S. pseudintermedius Siphoviridae phages, Appl Microbiol Biotechnol 103,16,pp 6809-6823, June, 2019.
  2. Azam AH, Tanji Y, Peculiarities of Staphylococcus aureus phages and their possible application in phage therapy, Appl Microbiol Biotechnol 103(11), pp 4279-4289, April, 2019.
  3. Azam AH, Tanji Y, Bacteriophage-host arm race: An update on the mechanism of phage resistance in bacteria and revenge of the phage with the perspective for phage therapy, Appl Microbiol Biotechnol 103, 5, pp 2121 – 2131, January, 2019.
  4. Azam AH, Hoshiga F, Takeuchi I, Miyanaga K, Tanji Y, Analysis of phage resistance in Staphylococcus aureus SA003 reveals different binding mechanism for the closely related Twort-like phages ƒ³SA012 and ƒ³SA039, Appl. Microbiol. Biotechnol., 102,20, pp 8963-8977, 2018.
  5. Ong SP, Azam AH, Sasahara T, Miyanaga K, Tanji Y. Characterization of Pseudomonas lytic phages and their application as a cocktail with antibiotics in controlling Pseudomonas aeruginosa. Journal of Bioscience and Bioengineering, 129, 6, pp 693-699, 2020.
  6. Takeuchi I, Osada K, Azam AH, Asakawa H, Miyanaga K, Tanji Y. The presence of two receptor-binding proteins contributes to the wide host range of staphylococcal Twort-like phages, Appl Environ Microbiol 82, 19, pp 5763 – 5774, July, 2016.
  7. Chanthol P, Hanawa T, Azam AH, LeBlanc C, Ung P, Matsuda T, Onishi H, Miyanaga K, Tanji Y. Silviavirus phage ?MR003 displays a broad host range against methicillin-resistant Staphylococcus aureus of human origin. Appl Microbiol Biotechnol. 103, pp 7751-7765, July, 2019.
  8. Yuk S, Kamarisima, Azam AH, Miyanaga K, Tanji Y. The contribution of nitrate-reducing bacterium Marinobacter YB03 to biological souring and microbiologically influenced corrosion of carbon steel. Biochemical Engineering Journal, 156, 07520, 2020.

Kanate Thitiananpakorn  Ph.D. ƒ|ƒXƒhƒN (ƒƒ“ƒo[ƒy[ƒW‚̃gƒbƒvƒw)
  
   Email: d1634jichi.ac.jp
Šw@—ð
•½¬23”N03ŒŽ
•½¬27”N06ŒŽ
—ߘa02”N03ŒŽ

E@—ð
•½¬27”N09ŒŽ
—ߘa02”N04ŒŽ
—ߘa03”N04ŒŽ



ƒV[ƒiƒJƒŠƒ“ƒEƒBƒ[ƒg‘åŠw@”÷¶•¨ŠwêU@ƒ^ƒC@‘²‹Æ@

ƒ}ƒqƒhƒ“‘åŠw‘åŠw‰@@ˆãŠwŒ¤‹†‰È@“Ő«ŠwêU@CŽm‰Û’ö@ƒ^ƒC@‘²‹Æ@@
Ž©Ž¡ˆã‰È‘åŠw‘åŠw‰@ lŠÔ¶•¨ŠwŒnêU ¶‘Ì–hŒäˆãŠw•ª–ì@”ŽŽm‰Û’ö@‘²‹Æ


ƒ}ƒqƒhƒ“‘åŠw‘åŠw‰@@Þ—¿Šw•ª–ì@ƒ^ƒC@ƒŠƒT[ƒ`ƒAƒVƒXƒ^ƒ“ƒg
Ž©Ž¡ˆã‰È‘åŠw ˆãŠw•” Š´õE–ƉuŠwuÀ ×‹ÛŠw•”–å ƒ|ƒXƒhƒN
Ž©Ž¡ˆã‰È‘åŠw ˆãŠw•” Š´õE–ƉuŠwuÀ ×‹ÛŠw•”–å@TBRFƒ|ƒXƒhƒN 

@Žå—v˜_•¶iSelected Publicationsj

  1. Boonsiri T, Watanabe S, Tan XE, Thitiananpakorn K, Narimatsu R, Sasaki T, Takenouchi R, Satofo Y, Aiba Y, Kiga K, Sasahara T, Taki Y, Li YF, Zhang YC, Azam AH, Kawaguchi T, Cui L. 2020. Identification and characterization of mutations responsible for the ƒÀ-lactam resistance in oxacillin-susceptible mecA-positive Staphylococcus aureus. Scientific Reports 10(1): 16907.
  2. Thitiananpakorn K, Aiba Y, Tan XE, Watanabe S, Kiga K, Satofo Y, Boonsiri T, Li FY, Sasahara T, Taki Y, Azam AH, Zhang YC, Cui L. 2020. Association of mprF mutations with cross-resistance to daptomycin and vancomycin in methicillin-resistant Staphylococcus aureus (MRSA). Scientific Reports 10(1): 16107.
  3. Kiga K, Tan X-E, Rodrigo IC, Watanabe S, Aiba Y, Satofo Y, Li F-Y, Sasahara T, Cui B, Kawauchi M, Boonsiri T, Thitiananpakorn K, Taki Y, Azam AH, Suzuki M, Penadés JR, and Cui L. Development of CRISPR-Cas13a-based antimicrobials capable of sequence-specific killing of target bacteria. Nat Commun 11, 2934 (2020). 
  4. Aiba Y, Watanabe S, Tsukahara R, Umemoto N, Thitiananpakorn K, Boonsiri T, Li F-Y, Kiga K, Satofo Y, Tan X-E, Taki Y, Azam AH, Zhang Y, Sasahara T, Demitsu T, Cui L. Complete Genome Sequence of a Panton-Valentine Leukocidin-Negative Staphylococcus aureus Strain Isolated from a Patient with Pervasive Necrotizing Soft Tissue Infection. Microbiology Resource Announcements Jun 2020, 9 (23) e00295-20.
  5. Watanabe S, Cui B, Kiga K, Aiba Y, Tan XE, Sato'o Y, Kawauchi M, Boonsiri T, Thitiananpakorn K, Taki Y, Li FY, Azam H.A., Nakada Y, Sasahara T, and Cui L., Composition and Diversity of CRISPR-Cas13a systems in the genus Leptotrichia., Frontiers in Microbiology., 10:2838., 2019.
  6. Cui B, Watanabe S, Sato'o Y, Nihashi F, Aiba Y, Kiga K, Sasahara T, Tan XE, Kawauchi M, Boonsiri T, Thitiananpakorn K, Taki Y, Li FY, Imokawa S, Cui L. Complete genome sequence of the methicillin-resistant Staphylococcus aureus strain JMUB3031, isolated from a patient with fatal community-acquired pneumonia., Microbiol Resour Announc., 8:e01652-18., 2019.
  7. Watanabe S, Aiba Y, Tan XE, Li F.-Y, Boonsiri T, Thitiananpakorn K, Cui B, Sato'o Y, Kiga K, Sasahara T, and Cui L. Complete genome sequencing of three human clinical isolates of Staphylococcus caprae reveals virulence factors similar to those of S. epidermidis and S. capitis. BMC Genomics, 19:810., 2018.
  8. Kanprasoet, W, Jensen, LT, Sriprach S, Thitiananpakorn K, Rattanapornsompong K, Jensen AN. Deletion of mitochondrial porin alleviates stress sensitivity in the yeast model of Shwachman-Diamond syndrome. J Genet Genomics, 42:671-684., 2015.
  9. Jensen, AN, Chindaudomsate W, Thitiananpakorn K, Mongkolsuk S, Jensen LT. Improper protein trafficking contributes to artemisinin sensitivity in cells lacking the KDAC Rpd3p. FEBS Lett. 588(21):4018-25. 2014.

Srivani Veeranarayanan  Ph.D. ƒ|ƒXƒhƒN (ƒƒ“ƒo[ƒy[ƒW‚̃gƒbƒvƒw)
 
   Email: srivanijichi.ac.jp

Šw@—ð
2005”N05ŒŽ
2007”N05ŒŽ
2012”N03ŒŽ

E@—ð
2012”N04ŒŽ
2020”N10ŒŽ-


ƒ}ƒhƒ‰ƒX‘åŠwiƒCƒ“ƒhj—‰ÈŠw - ƒoƒCƒIƒeƒNƒmƒƒW[  ŠwŽm
ƒ}ƒhƒ‰ƒX‘åŠwiƒCƒ“ƒhjˆâ“`Šw CŽm
“Œ—m‘åŠw, ¶–½‰ÈŠw”ŽŽm  ”ŽŽm

“Œ—m‘åŠw@ŠwÛE—Z‡‰ÈŠwŒ¤‹†‰È@ƒ|ƒXƒhƒN
Ž©Ž¡ˆã‰È‘åŠw ˆãŠw•” Š´õE–ƉuŠwuÀ ×‹ÛŠw•”–å ƒ|ƒXƒhƒN

@Žå—v˜_•¶iSelected Publicationsj
  1. External stimulus responsive inorganic nanomaterials for cancer theranostics. M. S. Mohamed, S. Veeranarayanan, T. Maekawa and D. S. Kumar. Advanced Drug Delivery Reviews, 2018, doi.org/10.1016/j.addr.2018.
  2. Photodynamic therapy at ultra-low NIR laser power and X-Ray imaging using Cu3BiS3 nanocrystals. S. Veeranarayanan*, M. S. Mohamed*, A. C. Poulose*, M. Rinya, Y. Sakamoto, T. Maekawa and D. S. Kumar. Theranostics, 2018, 8, 5231–5245. (*Authors contributed equally).
  3. Self-assembled dual responsive micelles stabilized with protein for co-delivery of drug and siRNA in cancer therapy. M. R. Aji Alex, Chetan Nehate, S. Veeranarayanan, D. Sakthi Kumar, Ritu Kulshreshtha, Veena Koul. Biomaterials, 2017, 133, 94-106.
  4. FITC/Suramin Harboring Silica Nanoformulations for Cellular and Embryonic Imaging/Anti-Angiogenic Theranostics. S. Veeranarayanan, Aby CP, Sheikh MM, Yutaka N, Shosaku K, Toru M, D. Sakthi Kumar. J. Mater. Chem., B, 2015, 3, 8079.
  5.  Synergistic Targeting of Cancer and Associated Angiogenesis Exercising Triple Targeted-Dual Drug Silica Nanoformulations for Theragnostics. S. Veeranarayanan, Aby CP, Sheikh MM, Saino HV, Yutaka N, Yasuhiko Y, Toru M, Sakthi Kumar D. Small 2012, 8, 3476-3489.
  6. GD and transferrin nanoparticle composition. T Maekawa, Sakthi Kumar D, SM Mohamed, S. Veeranarayanan. US Patent 10765637.
  7. Drug Delivery Nanoparticle Composition. T Maekawa, Sakthi Kumar D, SM Mohamed, S. Veeranarayanan.  Japan Patent JP6321305B2.

“‡Žç@—SŒŽ (Yuzuki Shimamori)  Ph.D. ƒ|ƒXƒhƒN (ƒƒ“ƒo[ƒy[ƒW‚̃gƒbƒvƒw)
 
    y_shimamorijichi.ac.jp

Šw@—ð
2012”N03ŒŽ
2014”N03ŒŽ
2021”N03ŒŽ

E@—ð
2014”N04ŒŽ
2017”N10ŒŽ
2021”N02ŒŽ


H“cŒ§—§‘åŠw@¶•¨Ž‘Œ¹‰ÈŠw•”@‘²@ŠwŽm
ŒQ”n‘åŠw‘åŠw‰@@HŠwŒ¤‹†‰È@‘²@CŽm
ŒQ”n‘åŠw‘åŠw‰@@—HŠwêU@‘²@”ŽŽm

‘æˆê‰®»ƒpƒ“Š”Ž®‰ïŽÐ@»‘¢‰Û
Šò•Œ‘åŠw‘åŠw‰@@ˆãŠwŒnŒ¤‹†‰È@•aŒ´‘̐§ŒäŠw•ª–ì@Œ¤‹†ˆõ
Ž©Ž¡ˆã‰È‘åŠw ˆãŠw•” Š´õE–ƉuŠwuÀ ×‹ÛŠw•”–å ƒ|ƒXƒhƒN

@Žå—v˜_•¶iSelected Publicationsj
  1. Shimamori Y, Mitsunaka S, Yamashita H, Suzuki T, Kitao T, Kubori T, Nagai H, Takeda S, Ando H, Staphylococcal Phage in Combination with Staphylococcus epidermidis as a Potential Treatment for Staphylococcus aureus-Associated Atopic Dermatitis and Suppressor of Phage-Resistant Mutants. Viruses 2021; 13(1): 7.
  2. Shimamori Y, Pramono AK, Kitao T, Suzuki T, Aizawa S, Kubori T, Nagai H, Takeda S, Ando H,  Isolation and characterization of a novel phage SaGU1 that infects Staphylococcus aureus clinical isolates from patients with atopic dermatitis. Curr. Microbiol. 2021;10.1007/s00284-021-02395-y.
  3. –ž’‡ãĈê, “‡Žç—SŒŽ, ˆÀ“¡OŽ÷, ƒtƒ@[ƒW‚ª‹~‚¤×‹ÛŠ´õÇ, Œ»‘ã‰ÈŠw, 2019; 3: 61-65.
  4. Tsukamoto N, Kanazawa Y, Shimamori Y, Yoshida K, Takeda S, Identification of a morphogenic intermediate of the bacteriophage Mu Baseplate, Adv. in Microbiol. 2014; 4(3): 1155-1163.

Md Mahadi Hassan Ph.D. ƒ|ƒXƒhƒN@(ƒƒ“ƒo[ƒy[ƒW‚̃gƒbƒvƒw)
  
   Email: xxxxjichi.ac.jp

Šw@—ð
2012”N5ŒŽ
2014”N6ŒŽ

2020”N3ŒŽ

E@—ð
2015”N

2016”N

2021”N3ŒŽ


Bachelor of Pharmacy, Noakhali Science and Technology University, Bangladesh
Masterfs in Clinical Pharmacy and Pharmacology, Noakhali Science and
  Technology University, Bangladesh
PhD in Clinical Pharmaceutical Science, Kumamoto University, Japan


Officer
, Department of Research and Development, BEXIMCO Pharmaceuticals
Limited, Bangladesh
Officer, Department of Quality Assurance, Novartis (Bangladesh), Pharmaceuticals Limited
Ž©Ž¡ˆã‰È‘åŠw ˆãŠw•” Š´õE–ƉuŠwuÀ ×‹ÛŠw•”–å ƒ|ƒXƒhƒN

@Žå—v˜_•¶iSelected Publicationsj
  1. Coming soon.


  —› •ô‰F (Li Feng-Yu) ‘åŠw‰@¶i”ŽŽm‰Û’öj(ƒƒ“ƒo[ƒy[ƒW‚̃gƒbƒvƒw)
 
    bwongwoojichi.ac.jp
Šw@—ð
•½¬28”N07ŒŽ
•½¬28”N10ŒŽ
•½¬29”N04ŒŽ
•½¬31”N04ŒŽ

‘å˜Aˆã‰È‘åŠw (’†‘)
@ŠwŽm
Ž©Ž¡ˆã‰È‘åŠw‘åŠw‰@ˆãŠwŒ¤‹†‰È@Œ¤‹†¶
Ž©Ž¡ˆã‰È‘åŠw‘åŠw‰@ˆãŠwŒ¤‹†‰È@‘åŠw‰@¶ iCŽm‰Û’öj
Ž©Ž¡ˆã‰È‘åŠw‘åŠw‰@ˆãŠwŒ¤‹†‰È@‘åŠw‰@¶ i”ŽŽm‰Û’öj



ìŒû ’qŽj (Tomohumi Kawaguchi ) ‘åŠw‰@¶i”ŽŽm‰Û’öj (ƒƒ“ƒo[ƒy[ƒW‚̃gƒbƒvƒw)
 
    kwgctmfmjichi.ac.jp
Šw@—ð
•½¬31”N03ŒŽ
—ߘa02”N04ŒŽ
—ߘa03”N03ŒŽ
—ߘa03”N04ŒŽ~

–¾Ž¡–ò‰È‘åŠw–òŠw•”¶–½‘n–ò‰ÈŠw‰È@‘²‹Æ
Ž©Ž¡ˆã‰È‘åŠwˆãŠw•”Š´õE–ƉuŠwuÀ×‹ÛŠw•ª–ì@Œ¤‹†¶
–¾Ž¡–ò‰È‘åŠw‘åŠw‰@–òŠwŒ¤‹†‰È¶–½‘n–ò‰ÈŠwêU ”ŽŽm‰Û’ö(‘OŠú)@C—¹@
Ž©Ž¡ˆã‰È‘åŠwˆãŠw•”Š´õE–ƉuŠwuÀ×‹ÛŠw•ª–ì@‘åŠw‰@¶i”ŽŽm‰Û’öj



Sowmiya Sankaranarayanan ‘åŠw‰@¶i”ŽŽm‰Û’öj (ƒƒ“ƒo[ƒy[ƒW‚̃gƒbƒvƒw)
 
   Email: xxxjichi.ac.jp
Šw@—ð
•½¬xx”N0xŒŽ
—ߘaxx”N0xŒŽ
—ߘa0x”N0xŒŽ~
—ߘa03”N04ŒŽ~

xxx
@ŠwŽm
xxx@CŽm‰Û’ö
xxx
Ž©Ž¡ˆã‰È‘åŠw‘åŠw‰@ˆãŠwŒ¤‹†‰È@”ŽŽm‰Û’ö



’£@Œ´½ (Zhang Yuancheng) ‘åŠw‰@¶iCŽm‰Û’öj (ƒƒ“ƒo[ƒy[ƒW‚̃gƒbƒvƒw)
 
  hangyc23jichi.ac.jp
Šw@—ð
•½¬30”N07ŒŽ
•½¬31”N12ŒŽ
—ߘa02”N04ŒŽ~

‹g—щ»HŠw‰@i’†‘j‘²‹Æ
@ŠwŽm
Ž©Ž¡ˆã‰È‘åŠw‘åŠw‰@ˆãŠwŒ¤‹†‰È@Œ¤‹†¶
Ž©Ž¡ˆã‰È‘åŠw‘åŠw‰@ˆãŠwŒ¤‹†‰È@CŽm‰Û’ö


Maniruzzaman ‘åŠw‰@¶iCŽm‰Û’öj (ƒƒ“ƒo[ƒy[ƒW‚̃gƒbƒvƒw)
 
   m.zamanjichi.ac.jp
Šw@—ð
Nov 2009
Jun 2013
Dec 2020
Apr 2021

E@—ð
Nov 2009

Apr 2012

Jan 2018

Jul 2019

Bachelor of Pharmaceutical Science, Bangladesh University

Master of Pharmaceutical Science, State University of Bangladesh@
Research Student, Jichi Medical University
Master's course student, Jichi Medical University


Executive, Department of Quality Assurance, Beacon Pharmaceuticals Limited,
               Bangladesh
Assistant Manager, Department of Quality Assurance,
               Navana Pharmaceuticals Limited, Bangladesh
Assistant Manager, Department of Quality Assurance,
               NAAFCO Pharmaceuticals Ltd, Bangladesh
Plant Manager, Manufacturing Unit, Newtec Pharmaceuticals Ltd, Bangladesh


 


—«@œ}iLiu Yij ‘åŠw‰@¶iCŽm‰Û’öj (ƒƒ“ƒo[ƒy[ƒW‚̃gƒbƒvƒw)
 
  s2109jichi.ac.jp
Šw@—ð
2017”N07ŒŽ
2021”N03ŒŽ
2021”N04ŒŽ-

@¼“ìˆã‰È‘åŠw ˆãŠw•”i’†‘jŠwŽm

@“Œ‹žƒ[ƒ‹ƒh“ú–{ŒêŠwZ —¯Šw
@Ž©Ž¡ˆã‰È‘åŠw‘åŠw‰@ˆãŠwŒ¤‹†‰È@CŽm‰Û’ö

 


Sarah hossain ‘åŠw‰@¶iCŽm‰Û’öj (ƒƒ“ƒo[ƒy[ƒW‚̃gƒbƒvƒw)
 
   sarahjichi.ac.jp

Šw@—ð
Jul 2016
Aug 2020
Apr 2021

E@—ð
Jul 2016


Bachelor of Medical Science, Southern Medical College, Bangladesh
Research Student, Jichi Medical University
Master's course student, Jichi Medical University


Medical Officer, CSCR Hospital, Bangladesh



 

 

 

 

 

 



  ¬¼ —² (Ryu Narimatsu) ˆãŠw•”¶@(ƒƒ“ƒo[ƒy[ƒW‚̃gƒbƒvƒw)
1 Šw@—ð

•½¬26”N `



•½¬26”N@Ž©Ž¡ˆã‰È‘åŠw‘åˆãŠw•”@“üŠw





  ’r“c Œ›¶ (Noriki Ikeda) ˆãŠw•”¶@(ƒƒ“ƒo[ƒy[ƒW‚̃gƒbƒvƒw)
2  Šw@—ð

•½¬26”N `



•½¬26”N@Ž©Ž¡ˆã‰È‘åŠw‘åˆãŠw•”@“üŠw

@




  ˆÉ“¡@”ü˜a (Miwa Ito) ˆãŠw•”¶@(ƒƒ“ƒo[ƒy[ƒW‚̃gƒbƒvƒw)
3  Šw@—ð

•½¬28”N `



•½¬28”N@Ž©Ž¡ˆã‰È‘åŠw‘åˆãŠw•”@“üŠw

@




  ´…  çq (Chihiro Shimizu) ˆãŠw•”¶@(ƒƒ“ƒo[ƒy[ƒW‚̃gƒbƒvƒw)
4  Šw@—ð

•½¬29”N `



•½¬29”N@Ž©Ž¡ˆã‰È‘åŠw‘åˆãŠw•”@“üŠw





  Žà’J@Šw (Manabu Suzutani) ˆãŠw•”¶@(ƒƒ“ƒo[ƒy[ƒW‚̃gƒbƒvƒw)
5  Šw@—ð

•½¬27”N `



•½¬27”N@Ž©Ž¡ˆã‰È‘åŠw‘åˆãŠw•”@“üŠw

@




  ²X–Ø O•ã (Kosuke Sasaki) ˆãŠw•”¶@(ƒƒ“ƒo[ƒy[ƒW‚̃gƒbƒvƒw)
6  Šw@—ð

•½¬27”N `



•½¬27”N@Ž©Ž¡ˆã‰È‘åŠw‘åˆãŠw•”@“üŠw

@




  ’@‰Ã’C (Yoshidatsu Chen) ˆãŠw•”¶@(ƒƒ“ƒo[ƒy[ƒW‚̃gƒbƒvƒw)
7  Šw@—ð

•½¬28”N `



•½¬28”N@Ž©Ž¡ˆã‰È‘åŠw‘åˆãŠw•”@“üŠw

@


@’|”V“à —æò (Remi Takenouchi) ˆãŠw•”¶@(ƒƒ“ƒo[ƒy[ƒW‚̃gƒbƒvƒw)
8  Šw@—ð

•½¬28”N `



•½¬28”N@Ž©Ž¡ˆã‰È‘åŠw‘åˆãŠw•”@“üŠw

@









 
  ‚¨’m‚点new
 ‘åŠw‰@¶(”ŽŽm/CŽm)‚ð•åW‚µ‚Ü‚·BˆÈ‰º‚Ì•åW—v€‚ð‚²——‰º‚³‚¢B
          


 
˜A—æ


 




 Copyright © 2015 Dept. Bacteriology, Jichi Medical Univ. All Rights Reserved